United States v. Dominguez — Affirmed Tier III classification and dismissed medication-condition challenge as unripe

Case
United States of America v. Eric Dan Dominguez
Court
U.S. Court of Appeals for the Fifth Circuit
Judge
Jones; Southwick; Willett
Date Decided
September 2, 2026
Docket No.
25-11160
Topics
SORNA, Invited Error, Supervised Release, Ripeness
Source
Read the full opinion

Background

Eric Dan Dominguez was convicted in California in 1996 of two counts of continuous sexual abuse of a child under 14 and one count of lewd or lascivious acts involving a child under 14. Those convictions required him to register as a sex offender. He last registered in California in November 2022, then moved to Lubbock, Texas, around November 2023 without notifying authorities in either state.

After police contacts at Dominguez’s residence led a registration coordinator to investigate, authorities discovered that he had not registered. Dominguez pleaded guilty to violating the Sex Offender Registration and Notification Act and stipulated that his offense was a Tier III offense requiring lifetime registration. The district court sentenced him to 15 months in prison and five years of supervised release, including a condition requiring him to take mental-health medications prescribed by a licensed physician.

Dominguez appealed both his Tier III classification and the medication condition. He completed his prison sentence while the appeal was pending but remained subject to supervised release.

The Court’s Holding

The Fifth Circuit first held that Dominguez’s challenge to his Tier III classification was not moot. Although he had completed his prison sentence, the classification carried a continuing collateral consequence because Tier III offenders must register for life, while Tier I and Tier II offenders have shorter registration periods.

The court affirmed the Tier III classification under the invited-error doctrine. Dominguez expressly stipulated that his offense was Tier III, confirmed the factual resume at his plea hearing, and did not object when the presentence report relied on that stipulation. Because substantial arguments supported the classification, he received a sentence at the bottom of the Guidelines range, and he obtained benefits from his plea agreement, the court found no manifest injustice. It did not decide whether his California convictions independently qualified as Tier III offenses.

The court dismissed without prejudice Dominguez’s challenge to the prescribed-medication condition as unripe. No physician had prescribed medication under the condition, and Fifth Circuit precedent treats such a challenge as premature when the defendant may never be subjected to the disputed medication requirement.

Key Takeaways

  • A completed prison sentence does not moot a SORNA-tier challenge when the classification determines the duration of the defendant’s registration obligation.
  • A defendant who expressly stipulates to a SORNA classification and affirms that stipulation during the plea process may invite the alleged error, limiting appellate review to manifest injustice.
  • A challenge to a supervised-release medication condition is unripe when no medication has been prescribed under that condition.

Why It Matters

The decision underscores the appellate consequences of factual and legal stipulations made during plea proceedings. Even without deciding whether Dominguez’s underlying convictions independently satisfied Tier III criteria, the Fifth Circuit enforced his stipulation because he had affirmatively induced the classification and could not show manifest injustice.

The opinion also distinguishes mootness from ripeness in post-sentencing appeals: ongoing lifetime-registration consequences preserved the SORNA issue, while the possibility of a future medication prescription was too contingent for review.

✉️ Get tomorrow’s cases before your first coffee
Daily Case Law is our free morning digest — the most substantive new decisions, filtered to your jurisdictions and topics, each linking back here for the full analysis.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top